GlobeNewswire Inc.··Not SpecifiedMonte Rosa Therapeutics Bolsters Investor Relations Push with Major Conference Schedule
Monte Rosa Therapeutics ($GLUE) will present at TD Cowen and Jefferies conferences in May-June 2026, advancing three molecular glue degrader programs in clinical development.
GLUEautoimmune diseasesclinical-stage biotech